微波消融与部分肾切除术治疗cT1a患者肾功能下降。

Jessica Qiu, Guofen Yan, Aisha Kazeem, Laiba Murad, Priscilla Badu, Wendy Qi, Genevieve Lyons, Carlos Justo-Jaume, Daniel V Nguyen, Stephen Culp, Noah S Schenkman, Jennifer M Lobo
{"title":"微波消融与部分肾切除术治疗cT1a患者肾功能下降。","authors":"Jessica Qiu, Guofen Yan, Aisha Kazeem, Laiba Murad, Priscilla Badu, Wendy Qi, Genevieve Lyons, Carlos Justo-Jaume, Daniel V Nguyen, Stephen Culp, Noah S Schenkman, Jennifer M Lobo","doi":"10.52733/kcj22n3-r1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Microwave ablation (MWA) is an emerging treatment modality for clinical T1a (cT1a) small renal masses (SRM) with studies showing it has comparable oncological outcomes to partial nephrectomy (PN). However, more research is needed to the impact of each treatment on kidney function decline.</p><p><strong>Objective: </strong>To compare the progression of kidney function decline in patients with cT1a SRM treated with MWA or PN.</p><p><strong>Methods: </strong>This study included prospective data on patients treated between 2015-2021 with kidney function data collected from 2015-2024 from a single institutional database. Three outcomes for kidney function decline were examined: 30% decline in estimated glomerular filtration rate (eGFR) compared to pre-treatment, chronic kidney disease (CKD) upstaging compared to pre-treatment and eGFR <60 mL/min/1.73m<sup>2</sup>, and the composite endpoint of the previous two events. Cox proportional hazards models were used to compare outcomes between the two treatments.</p><p><strong>Results: </strong>Among 97 MWA and 49 PN included, MWA patients were older, had lower baseline eGFR, and higher rates of CKD prior to treatment. Univariate Cox proportional hazard model showed treatment modality was not significantly associated with reaching kidney decline endpoints. After adjusting for patient characteristics (age, race, baseline eGFR, Charlson Comorbidity Index), only baseline eGFR was associated with reaching kidney function endpoints.</p><p><strong>Conclusion: </strong>There was no statistically significant difference in kidney function decline between PN and MWA treatments for cT1a SRM. After adjusting for patient factors, the higher hazard for MWA was attenuated.</p>","PeriodicalId":74040,"journal":{"name":"Kidney cancer journal : official journal of the Kidney Cancer Association","volume":"22 3","pages":"85-91"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12382370/pdf/","citationCount":"0","resultStr":"{\"title\":\"Kidney function decline in cT1a patients treated with Microwave Ablation versus Partial Nephrectomy.\",\"authors\":\"Jessica Qiu, Guofen Yan, Aisha Kazeem, Laiba Murad, Priscilla Badu, Wendy Qi, Genevieve Lyons, Carlos Justo-Jaume, Daniel V Nguyen, Stephen Culp, Noah S Schenkman, Jennifer M Lobo\",\"doi\":\"10.52733/kcj22n3-r1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Microwave ablation (MWA) is an emerging treatment modality for clinical T1a (cT1a) small renal masses (SRM) with studies showing it has comparable oncological outcomes to partial nephrectomy (PN). However, more research is needed to the impact of each treatment on kidney function decline.</p><p><strong>Objective: </strong>To compare the progression of kidney function decline in patients with cT1a SRM treated with MWA or PN.</p><p><strong>Methods: </strong>This study included prospective data on patients treated between 2015-2021 with kidney function data collected from 2015-2024 from a single institutional database. Three outcomes for kidney function decline were examined: 30% decline in estimated glomerular filtration rate (eGFR) compared to pre-treatment, chronic kidney disease (CKD) upstaging compared to pre-treatment and eGFR <60 mL/min/1.73m<sup>2</sup>, and the composite endpoint of the previous two events. Cox proportional hazards models were used to compare outcomes between the two treatments.</p><p><strong>Results: </strong>Among 97 MWA and 49 PN included, MWA patients were older, had lower baseline eGFR, and higher rates of CKD prior to treatment. Univariate Cox proportional hazard model showed treatment modality was not significantly associated with reaching kidney decline endpoints. After adjusting for patient characteristics (age, race, baseline eGFR, Charlson Comorbidity Index), only baseline eGFR was associated with reaching kidney function endpoints.</p><p><strong>Conclusion: </strong>There was no statistically significant difference in kidney function decline between PN and MWA treatments for cT1a SRM. After adjusting for patient factors, the higher hazard for MWA was attenuated.</p>\",\"PeriodicalId\":74040,\"journal\":{\"name\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"volume\":\"22 3\",\"pages\":\"85-91\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12382370/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52733/kcj22n3-r1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney cancer journal : official journal of the Kidney Cancer Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52733/kcj22n3-r1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:微波消融(MWA)是临床T1a (cT1a)小肾肿块(SRM)的一种新兴治疗方式,研究表明其肿瘤预后与部分肾切除术(PN)相当。然而,每种治疗方法对肾功能下降的影响还需要更多的研究。目的:比较MWA和PN治疗cT1a SRM患者肾功能下降的进展情况。方法:本研究纳入了2015-2021年期间接受治疗的患者的前瞻性数据,这些患者的肾功能数据收集于2015-2024年,来自单一机构数据库。研究了肾功能下降的三个结局:估计肾小球滤过率(eGFR)与治疗前相比下降30%,慢性肾脏疾病(CKD)与治疗前和eGFR 2相比上升,以及前两个事件的复合终点。采用Cox比例风险模型比较两种治疗的结果。结果:在纳入的97例MWA和49例PN患者中,MWA患者年龄较大,治疗前eGFR基线较低,CKD发生率较高。单因素Cox比例风险模型显示,治疗方式与达到肾衰终点无显著相关。在调整患者特征(年龄、种族、基线eGFR、Charlson合并症指数)后,只有基线eGFR与达到肾功能终点相关。结论:PN与MWA治疗cT1a SRM患者肾功能下降差异无统计学意义。在对患者因素进行调整后,MWA的高危险性减弱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Kidney function decline in cT1a patients treated with Microwave Ablation versus Partial Nephrectomy.

Background: Microwave ablation (MWA) is an emerging treatment modality for clinical T1a (cT1a) small renal masses (SRM) with studies showing it has comparable oncological outcomes to partial nephrectomy (PN). However, more research is needed to the impact of each treatment on kidney function decline.

Objective: To compare the progression of kidney function decline in patients with cT1a SRM treated with MWA or PN.

Methods: This study included prospective data on patients treated between 2015-2021 with kidney function data collected from 2015-2024 from a single institutional database. Three outcomes for kidney function decline were examined: 30% decline in estimated glomerular filtration rate (eGFR) compared to pre-treatment, chronic kidney disease (CKD) upstaging compared to pre-treatment and eGFR <60 mL/min/1.73m2, and the composite endpoint of the previous two events. Cox proportional hazards models were used to compare outcomes between the two treatments.

Results: Among 97 MWA and 49 PN included, MWA patients were older, had lower baseline eGFR, and higher rates of CKD prior to treatment. Univariate Cox proportional hazard model showed treatment modality was not significantly associated with reaching kidney decline endpoints. After adjusting for patient characteristics (age, race, baseline eGFR, Charlson Comorbidity Index), only baseline eGFR was associated with reaching kidney function endpoints.

Conclusion: There was no statistically significant difference in kidney function decline between PN and MWA treatments for cT1a SRM. After adjusting for patient factors, the higher hazard for MWA was attenuated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信